Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...

At its GTC conference today, Nvidia announced that BYD and Geely, as well as Isuzu and Nissan, would use the chipmaker’s ...

Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong ...

Leaders often equate growth with success. But examples from Costco to Glenstone show that knowing when not to scale can ...

Updates to the program manual coming into effect on April 1 don't include wage increases, or a pension plan, says advocate ...

It’s not just red tape that’s limiting the supply of electricity in America. Grids are physical machines, and they’re short ...

Complementing existing industry-standard safety practices, NVIDIA Halos is a full-stack, comprehensive safety system designed ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics ...

Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 Obtained alignment with FDA and global regulators for planned Phase 3 trial design in ...

Squalene rounds out the antioxidant actives range. A lipid naturally found in human sebum, squalene provides both emollient and free-radical scavenging benefits, protecting skin against environmental ...

The Brain & Behavior Research Foundation (BBRF) today announced it will award $1 million in Distinguished Investigator Grants to 10 senior scientists conducting innovative research in neurobiological ...

Good afternoon, ladies and gentlemen, and welcome to the DocGo Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] This call is being recorded on March 16, 2026. I would now like ...